Avenue Therapeutics, Inc.

Q2 2024 13F Holders

Symbol
ATXI
CUSIP
05360L403
Type
Equity
Class
COM NEW
Num filings
11
Total reported value, excl. options
$407 k
Manager Report Date Value ($000) Shares Option Type